This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Owens, D. R. Search for Related Content Social Bookmarking                         What's this?

Optimising glycaemic control — the role of long-acting insulin analogues in basal insulin therapy

Diabetes Research Unit, Llandough Hospital, Penarth, Wales, owensdr{at}cf.ac.uk

Current insulin treatment regimens effectively combat post-prandial hyperglycaemia, but are unable to reinstate normal fasting plasma glucose concentrations. The advent of long-acting soluble insulin analogues, such as insulin glargine and insulin detemir, offers improved control of basal hyperglycaemia without increasing the risk of hypoglycaemia.

Key Words: glycaemic control • insulin treatment • basal insulin • insulin analogues • insulin glargine • insulin detemir.

The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 5, 403-406 (2002)
DOI: 10.1177/14746514020020051101


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?